The role of neutral endopeptidase in caerulein-induced acute pancreatitis.
Substance P (SP) is well known to promote inflammation in acute pancreatitis (AP) by interacting with neurokinin-1 receptor. However, mechanisms that terminate SP-mediated responses are unclear. Neutral endopeptidase (NEP) is a cell-surface enzyme that degrades SP in the extracellular fluid. In this study, we examined the expression and the role of NEP in caerulein-induced AP. Male BALB/c mice (20-25 g) subjected to 3-10 hourly injections of caerulein (50 μg/kg) exhibited reduced NEP activity and protein expression in the pancreas and lungs. Additionally, caerulein (10(-7) M) also downregulated NEP activity and mRNA expression in isolated pancreatic acinar cells. The role of NEP in AP was examined in two opposite ways: inhibition of NEP (phosphoramidon [5 mg/kg] or thiorphan [10 mg/kg]) followed by 6 hourly caerulein injections) or supplementation with exogenous NEP (10 hourly caerulein injections, treatment of recombinant mouse NEP [1 mg/kg] during second caerulein injection). Inhibition of NEP raised SP levels and exacerbated inflammatory conditions in mice. Meanwhile, the severity of AP, determined by histological examination, tissue water content, myeloperoxidase activity, and plasma amylase activity, was markedly better in mice that received exogenous NEP treatment. Our results suggest that NEP is anti-inflammatory in caerulein-induced AP. Acute inhibition of NEP contributes to increased SP levels in caerulein-induced AP, which leads to augmented inflammatory responses in the pancreas and associated lung injury.
Department of Pharmacology, National University of Singapore, Singapore.
Yung-Hua
YH
Koh
Shabbir
S
Moochhala
Madhav
M
Bhatia
D061354:Acinar Cells / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D000818:Animals; D002108:Ceruletide / Q000633:toxicity*; D006020:Glycopeptides / Q000633:toxicity; D008168:Lung / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D015260:Neprilysin / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D019283:Pancreatitis, Acute Necrotizing / Q000139:chemically induced* / Q000201:enzymology* / Q000473:pathology; D012333:RNA, Messenger / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D011897:Random Allocation; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D012720:Severity of Illness Index; D015244:Thiorphan / Q000633:toxicity
D006020:Glycopeptides; D012333:RNA, Messenger; D011994:Recombinant Proteins; D002108:Ceruletide; D015244:Thiorphan; D015260:Neprilysin; C008890:phosphoramidon